CAPTRUST FINANCIAL ADVISORS
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1512024
RALEIGH, NC
Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$974,859
+$266,663 QoQ
Shares Held
11,960
+5.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#247
of 499 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. ARWR ranks #24 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in ARWR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $974,859 | 11,960 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $708,196 | 11,295 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,171,385 | 17,644 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $683,660 | 19,822 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $269,216 | 17,039 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $247,589 | 19,434 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $320,991 | 17,074 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $291,305 | 15,039 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $206,488 | 6,748 | Shares | Sole | 2024-02-14 | |
| 2022-06-30 | $42,287 | 1,201 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $45,116 | 981 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $60,266 | 909 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $54,563 | 874 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $69,900 | 844 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $302,174 | 4,557 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $322,266 | 4,200 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $159,322 | 3,700 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $151,165 | 3,500 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $100,695 | 3,500 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||